PPH Legal Blog

Lany Standford, a type 2 diabetic, died after suffering a heart attack in May, 2007. He had been prescribed Avandia to regulate his insulin levels; however, the drug turned out to be more dangerous than the condition it was meant to treat.
Stanford’s family has filed a wrongful death lawsuit against the manufacturer, GlaxoSmithKline. According to […]

[Read more →]

The United States Food and Drug Administration has been investigating the drug Avandia for some time now. In early 2008, the FDA issued a warning letter to the drug’s manufacturer, GlaxoSmithKline, for postmarketing safety reporting failures.
The large manufacturer claims that any information that was withheld was done so by mistake. GlaxoSmithKline states that the missing […]

[Read more →]

The Fen-phen trial, in which three attorneys who represented Fen-phen users are on trial for looting a $200 million settlement, remains undecided after its second day of jury deliberation.  The trio of lawyers has been accused of conspiracy to commit wire fraud.  If found guilty, each defendant faces up to 20 years in prison and […]

[Read more →]

In the final stages of the trial, the lawyer-defendants involved in the Fen-phen trial called an adverse witness, class action guru Stanley Chesley, to testify on their behalf.   This move appears as a last ditch effort for the lawyer-defendants who lack experts willing to testify in their favor.
Chesley testified that he had been hired by […]

[Read more →]

In the recent trial of three prominent lawyers accused of taking $65 million from their clients’ lawsuit against makers of the diet drug Fen-phen, the defendant Melbourne Mills Jr. was recently hospitalized, delaying the trial.  In addition to the financial theft from their clients’ $200 million settlement, each of the lawyers is also accused of […]

[Read more →]